Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3675189011 | Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3675190019 | Sulfasalazine 500 mg rectal suppository | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | Is a | Sulfasalazine-containing product in rectal dose form | false | Inferred relationship | Some | ||
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | Has active ingredient | Sulfasalazine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | Has manufactured dose form | Rectal dose form (dose form) | false | Inferred relationship | Some | ||
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | Has manufactured dose form | Rectal suppository | true | Inferred relationship | Some | ||
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | Has unit of presentation | Suppository (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength numerator value | 500 | false | Inferred relationship | Some | 1 | |
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | Has basis of strength substance (attribute) | Sulfasalazine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | Has precise active ingredient | Sulfasalazine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength denominator unit (attribute) | Suppository (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | Is a | Sulfasalazine only product in rectal dose form | true | Inferred relationship | Some | ||
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | Plays role | Antiinflammatory therapeutic role | true | Inferred relationship | Some | ||
| Product containing precisely sulfasalazine 500 milligram/1 each conventional release rectal suppository (clinical drug) | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR